Compare AbCellera Biologics Inc (ABCL) vs Tidewater Inc (TDW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs Tidewater Inc — how do they compare? AbCellera Biologics Inc trades at $9.24 (market cap $2.99B), while Tidewater Inc trades at $91 (market cap $4.54B). The key difference: Tidewater Inc is the larger of the two by market cap. Which is the better fit depends on your goals.
| ABCL | TDW | |
|---|---|---|
Market Cap | $2.99B | $4.54B |
Sector | Health | Utilities |
52-Week High | $9.76 | $91.20 |
52-Week Low | $2.78 | $47.29 |
Enterprise Value | $2.58B | $4.58B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Tidewater Inc
Tidewater is the leading global provider of offshore support vessels (OSVs) to the energy industry. With the world's largest fleet of platform supply vessels (PSVs) and anchor handling tugs (AHTS), it provides critical logistics and marine support for offshore oil, gas, and renewable energy projects. Following a period of massive strategic consolidation, Tidewater is now focused on maximizing day rates and free cash flow in a supply-constrained market, positioning itself as a primary beneficiary of the multi-year offshore upcycle.
Read more on TDW →
